Pharmaceuticals, Journal Year: 2025, Volume and Issue: 18(5), P. 639 - 639

Published: April 27, 2025

Acute lymphoblastic leukemia (ALL) is a malignant tumor caused by abnormal proliferation of B-line or T-line lymphocytes in the bone marrow. Traditional treatments have limitations. Because their unique advantages, nanodrug delivery systems (NDDSs) show great potential treatment ALL. In this paper, pathological features ALL, limitations current therapeutic methods, and definition composition NDDSs were reviewed. Research strategies for use ALL discussed. addition, challenges future development directions also discussed, aiming to provide reference application diagnosis

Language: Английский